Pharmaceutical Preparations · DE · CIK 1062822
Pioneering medicines that transform patients' lives through research, development, and commercialization of drug candidates
Comparable business profile · signals at a glance
In the 90 days to Feb 25, 2026: 2 insiders bought $2.7M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 25, 2026 | Debbane RaymondDirector | Buy | 2,000 | $1.49 | $3K |
| Feb 23, 2026 | Debbane RaymondDirector | Buy | 100,000 | $1.47 | $147K |
| Feb 20, 2026 | Debbane RaymondDirector | Buy | 100,000 | $1.48 | $148K |
| Feb 19, 2026 | Debbane RaymondDirector | Buy | 50,000 | $1.44 | $72K |
| Feb 18, 2026 | Debbane RaymondDirector | Buy | 133,688 | $1.32 | $176K |
| Feb 17, 2026 | Debbane RaymondDirector | Buy | 76,857 | $1.31 | $101K |
| Feb 13, 2026 | Debbane RaymondDirector | Buy | 57,952 | $1.31 | $76K |
| Feb 2, 2026 | Artal Group S.A.Director,TenPercentOwner | Buy | 1,538,462 | $1.30 | $2.0M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.